Company Valuation: Guardant Health, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 10,168 2,786 3,283 3,775 13,160 12,586 - -
Change - -72.6% 17.84% 14.96% 248.64% -4.36% - -
Enterprise Value (EV) 1 10,370 2,912 3,255 4,077 13,462 13,047 12,946 12,701
Change - -71.91% 11.75% 25.27% 230.18% -3.08% -0.77% -1.89%
P/E ratio -25x -4.24x -6.32x -8.58x -30.8x -32.5x -43.6x -149x
PBR 15.8x 46.4x 20.7x -27.1x -134x -58.2x 111x 26.7x
PEG - -0.1x 0.2x 0.5x 4.57x 2.7x 1.7x 2.1x
Capitalization / Revenue 27.2x 6.2x 5.82x 5.11x 13.4x 9.6x 7.47x 5.84x
EV / Revenue 27.8x 6.48x 5.77x 5.52x 13.7x 9.95x 7.68x 5.89x
EV / EBITDA -26.7x -5.84x -7.46x -10.2x -61x -71.8x -405x 56x
EV / EBIT -25.2x -5.35x -5.76x -9.19x -30.8x -36.3x -52.1x -261x
EV / FCF -36.5x -7.53x -9.42x -14.8x -57.8x -68.3x -202x 86.2x
FCF Yield -2.74% -13.3% -10.6% -6.74% -1.73% -1.47% -0.5% 1.16%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -4 -6.41 -4.28 -3.56 -3.32 -2.918 -2.175 -0.6386
Distribution rate - - - - - - - -
Net sales 1 373.7 449.5 563.9 739 982 1,312 1,685 2,156
EBITDA 1 -388.7 -498.9 -436.3 -399.5 -220.8 -181.7 -31.99 226.8
EBIT 1 -411 -544.4 -564.7 -443.6 -437.2 -359.5 -248.6 -48.72
Net income 1 -405.7 -654.6 -479.4 -436.4 -416.3 -381.2 -263.2 -71.46
Net Debt 1 202.1 126.2 -28.67 302.6 302.4 460.4 360.1 115
Reference price 2 100.02 27.20 27.05 30.55 102.14 94.92 94.92 94.92
Nbr of stocks (in thousands) 101,656 102,436 121,380 123,555 128,839 132,600 - -
Announcement Date 23/02/22 23/02/23 22/02/24 20/02/25 19/02/26 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-32.53x9.95x-71.69x-.--% 12.59B
16.5x1.91x7.68x1.56% 9.82B
22.56x4x11.25x - 6.11B
21.87x7.57x17.11x2.64% 5.91B
21.19x3.58x11.11x1.92% 4.34B
128.21x3.61x22.78x-.--% 4.11B
16.86x - - 3.8% 2.82B
-26.06x3.6x-29.87x-.--% 2.69B
Average 21.07x 4.89x -4.52x 1.42% 6.05B
Weighted average by Cap. 12.74x 5.56x -13.07x 1.18%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. GH Stock
  4. Valuation Guardant Health, Inc.